We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01601613
Recruitment Status : Completed
First Posted : May 18, 2012
Last Update Posted : January 11, 2017
Information provided by (Responsible Party):
Novo Nordisk A/S